Exhibitor Product Service Categories


International Societies

Professional Associations


Certification and Recertification

Education, Teaching Aids and CME

Food Service, Nutrition and Lifestyle

Exercise Equipment

Food Service and Nutrition


Healthcare Facilities Design/Construction/Office Furniture

Insurance Services



Angiographic Viewers and Work Stations

Echocardiography Equipment

Imaging Equipment (e.g., CT, MRI, Nuclear, PET)

Information Technology

Electronic Health Records/Electronic Medical Records (EHR/EMR)

Electronic Information Services and Equipment

Physician Practice Services and Management

Technology—Computer Hardware, Software and/or Patient Management Tools with Medical Applications

Web-Based Image Management and Reporting Solutions

Medical Devices

Arrhythmia Monitoring Equipment

Blood Pressure Monitoring Equipment

Diagnostic Catheters and Devices

ECG Equipment

External Defibrillators




Interventional—Other Percutaneous, Endovascular and Cardiac Devices

Invasive Monitoring and Testing

Mechanical Cardiac Support Devices, Percutaneous and LVADs

Pacing and Rhythm Management Devices

Patient Temperature Management

Prostheses, Valves and Pumps


Medical Equipment

Clinical Laboratory and Testing Services

Exercise Testing

Medical Equipment/Furniture

Noninvasive Monitoring and Testing

Patient Monitoring Systems

Pulmonary Diagnostic Equipment




Diagnostic Medications

Therapeutic Medications


Publications, Books and Journals


Clinical Trials

Market Research

Statistical Research Tools


Eligibility to Exhibit:

Applicants that meet the following criteria will be deemed eligible to exhibit:

  • The Exhibitor’s products or services must be cardiovascular-related and professional in nature.
  • The Exhibitor must classify its product/wervice using at least one (1) of the product/service catgories listed on the application. Write-in categories will not be considered.
  • The Exhibitor's and the applicant’s goods or services to be exhibited are considered by ACC to be consistent with ACC’s scientific or public policies, positions, statements or guidelines. This also includes the parent or subsidiary corporation of the Exhibitor or goods and services thereof, which must also be deemed by ACC to be consistent with ACC’s scientific or public policies, positions, statements or guidelines.
  • The Exhibitor agrees to comply with all ACC Managment policies, rules, regulations, terms and conditions including those policies that govern the submission of the application, and all policies and rules adopted by ACC hereafter.
  • The applicant must be financially stable. ACC Management reserves the right to request data establishing the Exhibitor's financial stability, even if the Exhibitor has exhibited in the past. The pending or filing of bankruptcy or insolvency proceedings with respect to Exhibtor at or after the submission of its application will result in automatic cancellation, with all applicable penalties, of the Exhibitor's exhibit space, even though ACC Management may have accepted the Exhibitor's application.
  • Only products or services listed by the Exhibitor on the original application and approved by ACC Management may be exhibited.
  • All products marketed and promoted in the Expo that are available in the US and are regulated by the Food and Drug Administration (FDA) must meet FDA guidelines or be FDA-approved. Companies without FDA product approval should clearly indicate on their booths that their product is for display and education purposes only and is not approved and/or available for use in the US. In order to maintain the informational and educational objectives of the ACC Annual Scientific Session & Expo together with Word Congress of Cardiology, ACC Management reserves the right to deny exhibit participation of any companies intending to exhibit vitamins and supplements that are not regulated by the FDA and/or to disallow said products from being displayed in the Expo. Nutraceutical products will be permitted only if Exhibitor can demonstrate peer reviewed evidence of efficacy. It is the responsibility of the Exhibitor to ensure adherence to FDA regulations, policies, practices and guidelines, and all other applicable industry guidelines, concerning the demonstration, discussion, use and/or display of products, technologies and/or services at the ACC Annual Scientific Session & Expo.
  • ExpoSuites can only be secured by contracted ACC.22 Exhibitors.
  • Only Exhibitors in good standing with ACC Management are permitted to submit an application for an ExpoSuite. Exhibitors must settle any outstanding balances in order for their applications to be considered.
  • If the Exhibitor cancels or defaults on exhibit space, any contracted ExpoSuites will also be cancelled and cancellation fees will apply, as outlined in the ACC.22 Annual Scientific Session & Expo Rules, Regulations, Terms & Conditions.